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ABSTRACT
Background: “Jamu Pegal Linu” (traditional Indonesian herb for rheumatoid and gouty arthritis) is one of the most 
popular jamu  products manufactured and widely consumed in the community. Despite the claims that they are made of 
natural herbs, these kinds of jamu are susceptible for being counterfeited and adulterated with drugs that is potentially 
harmful for health. The aim of this study was to identify medicinal adulteration in jamu pegal linu products obtained from the 
market in Jakarta and surroundings. Method: This study was an experimental laboratory in a cross-sectional design. About 
450 samples of jamu pegal linu products were randomly chosen, and the products with different brands wereanalyzed for 
medicinal adulteration using a thin layer chromatography (TLC) method. Product labels of the adulterated jamu were also 
analyzed for the appropriateness of the product information. Results: Out of the 114 brands of jamu pegal linu analyzed, 
52 samples (45.6%) were positive for medicinal. The medicinal types detected were paracetamol (30.7%), phenylbutazone 
(20.4%), piroxicam (7.1%) and mefenamic acid (3.5%). Two samples of jamu has been contaminated with molds and found 
damp. Of the 52 samples positive medicinal, 92.3% include the registration number and only 30.8% include the expiration 
date in the product labels. About 44.2% include the name of ingredients compositions written incorrectly in the labels. 
Conclusion:  A. limited numbers of Jamu pegal linu products adulterated with medicinal still existed in the market.
Key words: jamu pegal linu, traditional medicine, adulteration, thin layer chromatography (TLC) 
ABSTRAK
Latar belakang: Obat tradisional/jamu kategori pegal-linu, salah satu jenis produk jamu yang penggunaannya 
paling luas di masyarakat, termasuk jenis sediaan jamu yang rawan untuk “dipalsukan” dengan penambahan senyawa 
kimia obat (BKO) ke dalam produk. Penelitian ini bertujuan memperoleh data yang dapat menunjang keamanan jamu, 
khususnya mengidentifi kasi senyawa kimia obat dalam produk jamu dengan indikasi pegal linu/asam urat yang beredar di 
wilayah Jakarta dan sekitarnya. Metode: Desain penelitian potong lintang, dengan sampel 450 produk jamu yang dipilih 
secara acak dari sejumlah pasar/toko jamu di wilayah Jakarta dan sekitarnya. Analisis BKO dalam jamu dilakukan secara 
kromatografi  lapis tipis (KLT), dan deteksi noda pada 254 nm (UV) dan 366 nm (fl uoresensi). Selain itu dilakukan juga 
analisis kelengkapan penandaan produk jamu yang teridentifi kasi mengandung BKO. Analisis dilakukan secara deskriptif. 
Hasil: ditemukan 52 sampel (45,6%) dari 114 merek jamu kategori pegal linu/asam urat yang positif mengandung BKO. 
Jenis BKO yang terdeteksi adalah parasetamol (30,7%), fenilbutazon (20, 4%), piroksikam (7,1%) dan asam mefenamat 
(3,5%). Ditemukan 2 sampel jamu yang telah tercemar jamur/kapang dan kondisi lembab. Dari 52 sampel jamu yang 
positif BKO 92,3% mencantumkan nomor registrasi, 30,8% mencantumkan tanggal kadaluarsa dan 44,2% mencantumkan 
komposisi dengan penulisan nama Latin simplisia yang salah. Kesimpulan: Banyak jamu dicampur senyawa obat kimia 
yang ilegal dan dapat membahayakan kesehatan. Saran: Badan POM selalu melakukan surveillance terhadap produk 
jamu bermasalah dan menarik dari pasaran.
Kata kunci: jamu pegal linu, bahan kimia obat, kromatografi  lapis tipis
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INTRODUCTION
Jamu is a traditional Indonesian herb widely 
used for centuries with various indications, mainly 
for maintaining physical fitness and health, as well as 
helping cure the diseases. Among them, “Jamu Pegal 
Linu” (traditional Indonesian herb for rheumatoid and 
gouty arthritis) is a kind of jamu which is the most 
popular products manufactured and widely used in 
the community.1, 2 These kinds of jamu are susceptible 
for being counterfeited and adulterated with drugs, 2-4 
despite claims that they are made of natural herbs.
The National Agency for Drug and Food Control 
(NA DFC) or Badan POM has been repeatedly recalled 
some Jamu products due to adulterations with drugs 
which are harmful for consumers. 5–10 However, some 
medicinal adulterated products probably still available 
in the market and could be used by consumers. Jamu 
Pegal Linu often adulterates with certain drugs such 
as phenylbutazone, piroxicam, mefenamic acid, 
methampyrone, acetaminophene (paracetamol), 
dexamethasone and allopurinol, and this could be 
harmful for health if consumed continuously in a long 
period with uncontrolled dosage. 
 The aim of this study was to identify any 
adulteration which was still found in Jamu Pegal 
Linu that was available in the market, in Jakarta and 
surroundings.
METHODS 
This study was an experimental laboratory in a 
cross-sectional designed. Samples were 450 Jamu 
Pegal Linu products, randomly chosen from the market 
and jamu store/retail in Jakarta, Tangerang, Bekasi 
and Depok, and obtained in June 2010. Samples 
should meet the inclusion criteria, i.e. orally used 
only, includes 10-jamu pegal linu products retailer 
expressed as a product of the “best-selling” (most 
often purchased by consumers), registered or not. 
Medicinal adulterations were identified qualitatively 
using a thin layer chromatographic (TLC) method.11, 
12 In this method, we used a mixture of Chloroform-
Methanol (90:10) and Chloroform-Acetone (80:20) as 
a solvent (mobile-phase), and a TLC plate Silica Gel 
254 and visualized the spot with UV lamp at 254 nm 
and 366 nm wave length. Product labeling was also 
analyzed in order to know if the product label provides 
appropriate information or not. 
RESULTS 
Out of 450 jamu products sampling from Jakarta 
and surroundings, about 114 which had different brand 
names, had been analyzed for medicinal adulteration. 
Most (83.3%) of the various brands of jamu pegal 
linu products had registered (the registration number 
included in the packaging), and only 32.5% of them 
that include an expiration date; almost all of them 
presented in powders and capsules, and a small 
portion in the form of pills (Table 1). Two products in 
capsules found damp and contaminated with molds.
Of 114 jamu brands being evaluated, 52 (45.6%) 
products were found adulterated with medicinal. 
Results from TLC analyzing, it was found that some 
jamu products contained mefenamic acid (4 products, 
3.5%), piroxicam (8 products, 7.0%), phenylbutazone 
(23 products, 20.2%), paracetamol (35 products, 
30.7%), and none containing dexamethasone (Table 
2) and (Figure 2 and 3).
Product labeling analyzed from 52 adulterated 
jamu brands showed that most of them (92.3%) had 
a registration number, only 4 had none; expiration 
date included in the labels of 16 (30.8%) products; 
five products did not include the herbs composition, 
and about 44.2% had the herbal names (simplicia) 
in the composition written incorrectly. Indication and 
posology of the herbal included in all product labels, 
Table 1. Characteristic of Jamu Pegal Linu Products 
Analyzed (N = 114)
Items N %
Dosage form:
Powder 53 46.5
Capsule* 47 41.2
Pill 14 12.3
Registration number included 95 83.3
Expiration date included 37 32.5
Figure 1. Example of Jamu product contaminated with 
molds
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Table 2. Medicinal Found in Adulterated Herbal 
(Jamu Pegal Linu) Products (N = 114)
N %
Medicinal not found 62 54.4
Medicinal found 52 45.6
Sort of medicinal:
Paracetamol 35 30.7
Phenylbutazone 23 20.2
Piroxicam 8 7.0
Mefenamic acid 4 3.5 
Dexamethasone 0 0
Figure 2. Example of TLC Chromatogram of Mefenamic Acid and Piroxicam
PiroxicamMefenamic acid
Figure 3. Example of TLC Chromatogram of Phenylbutazone and Paracetamol
Phenylbutazone Paracetamol
Table 3. Product Labeling Items Included in the 
Adulterated Jamu (N = 52)
Items 
 Available in 
the product label 
N %
Registration number 48 92.3
Expiration date 16 30.8
Production code  8 15.4
Composition (ingredient) of 
the herbal product:
written correctly 24 46.2
written incorrectly 23 44.2
Indication, posology 52 100.0
Contra-indication, 
precaution 
15 28.8
Storage method  1 1. 9
but contra-indication and warning/precaution only 
found in 15 products; only one gave the information 
about the storage method. (Table 3). 
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DISCUSSION
Jamu Pegal Linu is a kind of jamu which is the most 
extensive herbal product used in the community. This 
herbal product can be purchased directly by consumer 
without prescription. Approximately 40% of jamu users 
consume this kind of herbal continuously and regularly 
for a period of 1 year.2 Jamu Pegal Linu is susceptible 
for being counterfeited and adulterated with medicinal 
that is prohibited to put in the composition of herbal 
product.2-4 Herbal products that contain medicinal, 
notably prescription drugs, can be harmful to health 
since the appropriate dosage cannot be controlled. 
However, results from this study revealed that some 
herbal products (45.6%) sampled in the market still 
found adulterated with medicinal including prescription 
drug. 
Most types of drugs detected were paracetamol 
(35 samples, 30.7%) and phenylbutazone (23 samples 
or 20.4%). Phenylbutazone is a well-known medicinal 
which is the “favorite” to be added to the herbal 
product, particularly herbal for arthritis or jamu 
pegal linu. Obviously from the number of herbal 
products that have been withdrawn from the market 
by NA FDC, most are herbal products that contain 
phenylbutazone.5,7
Phenylbutazone is a non steroid anti-inflammatory 
drug (NSAID), and has a strong anti-inflammatory, 
antipyretic, and analgesic activities. It is especially 
effective in the treatment of ankylosing spondylitis. 
It is also useful in rheumatoid and gouty-arthritis. 
However, this drug has numerous adverse effects; 
some could be serious, especially in prolonged 
use with uncontrolled dosage. Phenylbutazone 
adverse effects are similar to those of other NSAIDs 
including nausea, vomiting, skin rash, water retention 
(edema), GI ulcers, blood dyscrasias, and renal 
failure.13 Besides its strong anti-inflamatory effect or 
frequently expressed by the consumer as “cespleng” 
(= potent), it is likely --due to the relatively low price 
of phenylbutazone-- caused the producers mixing 
this drug into jamu.
Paracetamol is an analgesic-antipyretic drug 
relatively safe if it is used in therapeutic dose. This is 
an OTC drug which can be sold directly to consumer 
without prescription. Although it is relatively safe, 
the addition to herbal product is illegal, especially 
because of the dosage used might be uncontrolled 
and overdosed. Prolonged use and high dosage of 
paracetamol may cause liver damage.14 
Two other drugs indentified in the herbal product 
with TLC method were piroxicam (8 samples or 
7.1%) and mefenamic acid (4 samples or 3.5%). 
These drugs are also a strong NSAID and more 
expensive than phenylbutazone. Piroxicam is often 
prescribed by doctors for the treatment of rheumatoid 
arthritis and gouty arthritis. The common adverse 
effect of piroxicam is gastrointestinal upset and the 
more serious is the onset of peptic ulcers.15,16 Other 
adverse effects include headache, tinnitus, and 
erythema. Piroxicam is contraindicated for pregnancy 
and patients with peptic ulcer. Mefenamic acid has 
several adverse reactions, the most common is 
gastrointestinal effects (included abdominal pain, 
gastric/duodenal ulcers, gross bleeding/perforation, 
dyspepsia, constipation, diarrhea, f latulence, 
heartburn, nausea, and vomiting). Hematological 
adverse reactions have also reported included anemia, 
increased bleeding time, ecchymosis, eosinophilia, 
leucopenia, purpura, and thrombocytopenia. 
Respiratory side effects have included asthma and 
dyspnea; while renal adverse effects include abnormal 
renal function and renal failure.17,18 Mefenamic acid 
is contraindicated for patients with GI ulcers, asthma 
and renal dysfunction. 
Results from analyzing of product labels of the 
52 jamu products which have been counterfeited 
with medicinal, showed that most products (92.3%) 
had registration numbers included in the package 
labels and four products did not have registration 
number. However, it should be proven whether the 
registration number is authentic or spurious/pseudo-
number. Based on data retrieval of traditional medicine 
in the NA FDC,19 in this study it was identified that 
only 6 samples of products registered. The rest still 
need to be investigated regarding the validity of the 
registration number. When withdrawn some traditional 
medicine products containing drug from the market, 
apparently NA FDC also found a number of products 
that use fake registration number.9 
Expiration date of the product is required to ensure 
the product is safe to use up to a specified date. 
Approximately 30.8% of the adulterated products 
included the expiration date. It was found in this study 
that two products expired when purchased (expiration 
by June 2005 and October 2008). Herbal products that 
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contain simplicia prone to be contaminated with mold/
fungal and damp, especially galenic preparations 
extract. In this study, it was found that two jamu 
capsules had contaminated with mold and physically 
damp, although the products were still not beyond the 
expiration date; which means that those products, 
based on the expiration date, were still appropriate for 
consumption. Mold contamination might be dangerous 
if that is the Aspergillus flavus, because it is a fungal 
that produces aflatoxin.20 Mold contamination may be 
caused by inadequate storage conditions (humid), or 
contamination has been occurred since the start of the 
raw materials processing. Contamination in herbal raw 
materials may occur if post-harvest drying process is 
not appropriate. Beside the expiration date, method 
of storage is also important. All of jamu products 
being observed in this study did not include method 
of storage in their packaging labels.
Composition of the ingredient in an herbal product 
determines the indication of the product. Most of 
jamu products observed in this study consist of 4–7 
simplicia in their compositions. There is one product 
that includes up to 15 different types of simplicia. The 
herbal (simplicia) names were written in Latin, but 
44.2% were written incorrectly. For example, there 
were written coptici fructus instead of capsici fructus, 
minosa pudica instead of Mimosa pudica, diper 
nigrum instead of Piper nigrum, ngristica program 
instead of Myristica fragrans, gladziosa superbal 
instead of Gloriosa superba, and so on. One of the 
quality assurance of a product (including products of 
traditional medicine/herbal medicine), among others 
is the validity of the content or composition of the 
active ingredients. Errors in writing the herbal name, in 
addition to detected moldy product samples, indicating 
the possibility of the production of herbal medicine 
has not yet follow the good manufacturing practice 
for traditional medicine (GMP), so the product quality 
may still questionable.
Out of 52 samples positive adulterated with 
medicinal, five products did not include the composition 
of active ingredients in the packaging labels, and three 
of them unregistered (did not have a registration 
number). One of the unregistered products was a 
Chinese traditional medicine (TCM) with almost all 
information in the packaging label written in Chinese, 
except the product name written and translated as 
“Asam Urat”. Indications included in all adulterated 
products, but only 15 (28.8%) products have contra-
indication and precaution/warning written in the labels, 
mostly a warning to “avoid consuming foods such as 
nuts” (“hindari makanan berupa kacang-kacangan”). 
Precaution and contraindication for pregnancy and 
ulcers stated in 4 adulterated products.
Self-medication for minor ailments and complaints 
by consuming traditional herbal medicine ( jamu) 
should be done rationally and safely. With a number 
of herbal products containing drugs (adulterated 
jamu) still existed in various markets in Jakarta and 
surroundings, people still exposed to the possibility of 
taking jamu products which are dangerous and can be 
harmful to health. Beside manufactured jamu (branded 
jamu) found adulterated with medicinal, presumably 
there are also ‘ready-to-consume’ herbals (such as 
jamu gendong) which taken directly by consumers, 
that purposely mixed with medicinal by the seller. To 
proof this assumption, another comprehensive study 
is required.
CONCLUSION
Although in limited numbers, jamu pegal linu 
products adulterated with medicinal still existed in the 
market. Medicinal mixed into the herbal products, is 
illegal and can be harmful to health. The government, 
i.e. NA FDC (Badan POM), is expected to continuously 
performed surveillance to the adulterated products 
and withdrawn them from the market.
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